啟迪古漢(000590.SZ)2019年度淨利潤4244.23萬元 實現扭虧為盈
格隆匯4月8日丨啟迪古漢(000590.SZ)披露2019年年度報告,實現營業收入3.15億元,同比增長69.55%;歸屬於上市公司的淨利潤4244.23萬元,實現扭虧為盈;歸屬於上市公司股東的扣除非經常性損益的淨利潤2230.49萬元;基本每股收益0.1772元,公司計劃不派發現金紅利,不送紅股,不以公積金轉增股本。
公司所處的行業為醫藥製造業,主要致力於研究、開發中國中藥傳統祕方、驗方和西藥製劑,可生產古漢養生精(口服液、片劑)、養心定悸顆粒等中成藥以及大容量注射劑、原料藥等西藥製劑。主要產品和服務廣泛應用於治療以及醫療保健的各個領域。公司生產的核心產品為古漢養生精,是根據長沙馬王堆漢墓出土的竹簡醫書《養生方》,精選地道中藥材,運用現代科技研製而成的純中藥製劑,具有治療兼保健功能的“準”字號藥品,主要功效為補氣、滋腎、益精。經過三十多年的發展,在湖南省內市場取得了良好的業績和市場佔有率。近年來公司正在努力拓展和培育全國市場。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.